FGF21 is one of the most potent insulin sensitizers (3) and since insulin resistance is one of the most important factors in NAFLD development, FGF21 with this mechanism can ameliorate NAFLD (18). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.